A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals

The Journal of Antimicrobial Chemotherapy
R J BywaterJohn Walters

Abstract

To study antimicrobial resistance in zoonotic bacteria isolated from food animals in different countries using uniform methodology. Samples were taken at slaughter from chickens, pigs and cattle in four EU countries per host. Escherichia coli (indicator organism; n = 2118), Salmonella spp. (n = 271) and Campylobacter spp. (n = 1325) were isolated in national laboratories and MICs tested in a central laboratory against, where appropriate, ampicillin, cefepime, cefotaxime, ciprofloxacin, chloramphenicol, erythromycin, gentamicin, nalidixic acid, streptomycin, tetracycline and trimethoprim/sulfamethoxazole. Isolation rates were high for E. coli, low for Salmonella and intermediate for Campylobacter. MIC results showed resistance prevalence varied among compounds, hosts and countries. For E. coli and Salmonella, resistance to newer compounds (cefepime, cefotaxime, ciprofloxacin) was absent or low, but to older compounds (except gentamicin), resistance was variable and higher. E. coli isolates from Sweden showed low resistance, whereas among isolates from Spain (pigs), resistance to ampicillin, chloramphenicol, streptomycin, tetracycline and trimethoprim/sulfamethoxazole was higher; the UK, France, the Netherlands, Germany, Italy an...Continue Reading

References

Nov 1, 1985·Antimicrobial Agents and Chemotherapy·D E TaylorH Lior
Sep 28, 1999·Nature·M A GilliverC A Hart
Jan 20, 2000·Antimicrobial Agents and Chemotherapy·K KeyesM D Lee
Jun 9, 2001·International Journal of Antimicrobial Agents·S SchwarzT R Walsh
Jul 10, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R BaxA White
Dec 6, 2001·Revue Scientifique Et Technique·D G WhiteUNKNOWN Office International des Epizooties Ad hoc Group
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·Gunnar Kahlmeter, Derek F J Brown
Dec 25, 2002·Emerging Infectious Diseases·Irving NachamkinMing Li
Jun 6, 2003·Applied and Environmental Microbiology·G Douglas Inglis, Lisa D Kalischuk
Feb 10, 2004·Applied and Environmental Microbiology·Artashes R KhachatryanDouglas R Call
Mar 20, 2004·The Journal of Infectious Diseases·Alessandro BartoloniGian Maria Rossolini
Dec 1, 2002·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Manfred Kist

❮ Previous
Next ❯

Citations

Mar 7, 2008·New Zealand Veterinary Journal·M F NulsenD E B Lawton
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leanne E UnicombUNKNOWN Australian Campylobacter Subtyping Study Group
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David H Lloyd
Mar 10, 2011·Foodborne Pathogens and Disease·Jonathan G FryePaula J Fedorka-Cray
Apr 6, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·N NolletD Maes
Oct 24, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Boudewijn CatryAnnemie Decostere
Jul 27, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Boudewijn CatryAart De Kruif
Mar 7, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Thorunn R ThorsteinsdottirEggert Gunnarsson
Nov 26, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jonathan G FryeMarkus Rose
Dec 5, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Davy PersoonsFreddy Haesebrouck
Sep 5, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ivan LiterakJiri Klimes
Aug 26, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Eunju Shin, Yeonhee Lee
Aug 31, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Davy PersoonsJeroen Dewulf
Feb 9, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·David Pérez-BotoM Aurora Echeita
Aug 23, 2011·Applied and Environmental Microbiology·Maria KarczmarczykSéamus Fanning
Nov 14, 2006·Applied and Environmental Microbiology·Ashish A SawantBhushan M Jayarao
Feb 13, 2007·Applied and Environmental Microbiology·C B D'limaS Kathariou
Mar 21, 2007·Applied and Environmental Microbiology·Marjaana HakkinenMarja-Liisa Hänninen
Jun 6, 2006·Applied and Environmental Microbiology·Sarah C DonaldsonBhushan M Jayarao
Jun 6, 2006·Applied and Environmental Microbiology·G Douglas InglisAnno de Jong
Feb 8, 2006·Applied and Environmental Microbiology·Joo-Sung KimSophia Kathariou
Oct 7, 2011·Clinical Microbiology Reviews·Bonnie M Marshall, Stuart B Levy
Feb 7, 2009·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Zoran TamburDubravko Bokonjić
Feb 26, 2011·International Journal of Food Microbiology·Shang-Shang QinJian-Zhong Shen
Jun 21, 2014·Zoonoses and Public Health·A-K LlarenaM-L Hänninen
Mar 1, 2008·International Journal of Antimicrobial Agents·Anna FàbregaJordi Vila

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.